Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 16498631)

Published in Glia on April 15, 2006

Authors

Yoshinori Hayashi1, Hitoshi Ishibashi, Kenji Hashimoto, Hiroshi Nakanishi

Author Affiliations

1: Laboratory of Oral Aging Science, Faculty of Dental Sciences, Kyushu University, Fukuoka, Japan.

Articles citing this

The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS. Glia (2012) 1.59

Microglia control neuronal network excitability via BDNF signalling. Neural Plast (2013) 1.08

Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. J Neuroinflammation (2013) 1.03

Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic? Curr Med Chem (2014) 1.02

Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98

Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone. Neuroscience (2015) 0.95

Susceptibility to Calcium Dysregulation during Brain Aging. Front Aging Neurosci (2009) 0.91

Microglial control of neuronal activity. Front Cell Neurosci (2013) 0.89

Glycine and glycine receptor signalling in non-neuronal cells. Front Mol Neurosci (2009) 0.87

Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology (2011) 0.87

Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nat Commun (2016) 0.85

Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study. Psychiatry Res (2009) 0.84

Saikosaponin a mediates the anticonvulsant properties in the HNC models of AE and SE by inhibiting NMDA receptor current and persistent sodium current. PLoS One (2012) 0.83

Fine-tuning the central nervous system: microglial modelling of cells and synapses. Philos Trans R Soc Lond B Biol Sci (2014) 0.82

Microvesicles: What is the Role in Multiple Sclerosis? Front Neurol (2015) 0.81

Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases. Mediators Inflamm (2014) 0.80

Contributions of microglia to structural synaptic plasticity. J Exp Neurosci (2013) 0.79

Microglia-Neuron Communication in Epilepsy. Glia (2016) 0.78

NMDA Receptor Function During Senescence: Implication on Cognitive Performance. Front Neurosci (2015) 0.78

BK channels in microglia are required for morphine-induced hyperalgesia. Nat Commun (2016) 0.76

An EP2 Agonist Facilitates NMDA-Induced Outward Currents and Inhibits Dendritic Beading through Activation of BK Channels in Mouse Cortical Neurons. Mediators Inflamm (2016) 0.75

Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int J Mol Sci (2017) 0.75

Articles by these authors

(truncated to the top 100)

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry (2003) 3.12

Calcium signals: the lead currency of plant information processing. Plant Cell (2010) 2.87

Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc (2002) 2.68

Multicolor bimolecular fluorescence complementation reveals simultaneous formation of alternative CBL/CIPK complexes in planta. Plant J (2008) 2.44

Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 2.42

Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse. Biol Psychiatry (2011) 2.16

Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet (2004) 2.13

Developmental switch from GABA to glycine release in single central synaptic terminals. Nat Neurosci (2003) 1.93

Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol (2007) 1.88

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry (2005) 1.85

A ubiquitin-10 promoter-based vector set for fluorescent protein tagging facilitates temporal stability and native protein distribution in transient and stable expression studies. Plant J (2010) 1.75

Alternative O-GlcNAcylation/O-phosphorylation of Ser16 induce different conformational disturbances to the N terminus of murine estrogen receptor beta. Chem Biol (2006) 1.74

Inter-regional contribution of enhanced activity of the primary somatosensory cortex to the anterior cingulate cortex accelerates chronic pain behavior. J Neurosci (2011) 1.67

Microglial activation in schizophrenia and minocycline treatment. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.47

Phosphatidylserine-containing liposomes inhibit the differentiation of osteoclasts and trabecular bone loss. J Immunol (2010) 1.45

Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A (2014) 1.39

Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder. PLoS One (2012) 1.36

High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. Biol Psychiatry (2007) 1.33

Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem (2008) 1.29

NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice. J Neurosci (2008) 1.27

Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS One (2008) 1.24

Loss of mammalian Sprouty2 leads to enteric neuronal hyperplasia and esophageal achalasia. Nat Neurosci (2005) 1.24

D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav Brain Res (2007) 1.23

Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.23

The Calcineurin B-like calcium sensors CBL1 and CBL9 together with their interacting protein kinase CIPK26 regulate the Arabidopsis NADPH oxidase RBOHF. Mol Plant (2013) 1.22

Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol Cell Neurosci (2003) 1.21

Calcium-dependent modulation and plasma membrane targeting of the AKT2 potassium channel by the CBL4/CIPK6 calcium sensor/protein kinase complex. Cell Res (2011) 1.19

Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels. Biol Psychiatry (2005) 1.18

Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am J Psychiatry (2007) 1.17

Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One (2012) 1.17

MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin Cancer Res (2013) 1.17

Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol (2002) 1.16

Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J Neurosci (2008) 1.15

Induction of NMDA and GABAA receptor-mediated Ca2+ oscillations with KCC2 mRNA downregulation in injured facial motoneurons. J Neurophysiol (2002) 1.15

Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.15

FRET-based genetically encoded sensors allow high-resolution live cell imaging of Ca²⁺ dynamics. Plant J (2011) 1.13

Proteases involved in long-term potentiation. Life Sci (2002) 1.13

Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia. Schizophr Res (2002) 1.11

Proteomic analysis of acrylamide gel separated proteins immobilized on polyvinylidene difluoride membranes following proteolytic digestion in the presence of 80% acetonitrile. Proteomics (2003) 1.10

Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem (2002) 1.10

Peripheral IL-6 signaling: a promising therapeutic target for depression? Expert Opin Investig Drugs (2015) 1.10

Altered dendritic morphology of Purkinje cells in Dyt1 ΔGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice. PLoS One (2011) 1.10

Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.10

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Ann Gen Psychiatry (2010) 1.10

Rapid antidepressant effects and abuse liability of ketamine. Psychopharmacology (Berl) (2014) 1.09

Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.09

High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol (2009) 1.09

Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology (2007) 1.09

Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res (2004) 1.08

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study. PLoS One (2008) 1.08

Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered. Hum Psychopharmacol (2010) 1.07

Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography. Ann Nucl Med (2009) 1.06

Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis. Schizophr Bull (2011) 1.05

Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry (2003) 1.04

Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS One (2013) 1.04

Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. J Neurosci (2011) 1.04

Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacol Biochem Behav (2011) 1.04

Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLoS One (2011) 1.03

Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biol Psychiatry (2007) 1.02

Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis. J Clin Psychopharmacol (2013) 1.02

Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors. Ann Gen Psychiatry (2010) 1.02

Sustained depolarizing shift of the GABA reversal potential by glutamate receptor activation in hippocampal neurons. Neurosci Res (2008) 1.02

Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer. Cancer Res (2007) 1.02

Tropisetron improves deficits in auditory P50 suppression in schizophrenia. Schizophr Res (2005) 1.01

Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci Lett (2003) 1.01

Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol (2006) 1.01

Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.01

Alteration of plasma glutamate and glutamine levels in children with high-functioning autism. PLoS One (2011) 1.00

Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav (2012) 1.00

Specific metabolites in the medial prefrontal cortex are associated with the neurocognitive deficits in schizophrenia: a preliminary study. Neuroimage (2009) 1.00

Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. Curr Pharm Des (2012) 1.00

α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease. Open Med Chem J (2010) 1.00

Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1. J Immunol (2010) 0.99

Molecular cloning and characterization of a novel human beta 1,4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N,N'-diacetyllactosediamine, galNAc beta 1-4GlcNAc. J Biol Chem (2003) 0.99

Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch Gen Psychiatry (2010) 0.99

Phospholipase C-related inactive protein is involved in trafficking of gamma2 subunit-containing GABA(A) receptors to the cell surface. J Neurosci (2007) 0.99

Intraventricular meningioma with anaplastic transformation and metastasis via the cerebrospinal fluid. Neuropathology (2007) 0.98

Modulation of D-serine levels in brains of mice lacking PICK1. Biol Psychiatry (2008) 0.98

Combined intoxication with methylone and 5-MeO-MIPT. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.98

Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine. Neurosci Lett (2013) 0.97

The action of BDNF on GABA(A) currents changes from potentiating to suppressing during maturation of rat hippocampal CA1 pyramidal neurons. J Physiol (2003) 0.96

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors. Eur Neuropsychopharmacol (2007) 0.96

Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: a possible role of IP₃ receptors. Eur J Pharmacol (2010) 0.96

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.96

Activation of presynaptic GABAA receptors increases spontaneous glutamate release onto noradrenergic neurons of the rat locus coeruleus. Brain Res (2005) 0.94

Phospholipase C-related but catalytically inactive protein is required for insulin-induced cell surface expression of gamma-aminobutyric acid type A receptors. J Biol Chem (2009) 0.94

Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1beta. Neurobiol Dis (2010) 0.94

Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia (2010) 0.94

Synthesis and SAR of 1-hydroxy-1H-benzo[d]imidazol-2(3H)-ones as Inhibitors of D-Amino Acid Oxidase. ACS Med Chem Lett (2012) 0.94

Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study. J Clin Psychopharmacol (2010) 0.94

Secretion of saliva in X-irradiated rat submandibular glands. Radiat Res (2003) 0.93

Decreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patients. Schizophr Res (2007) 0.93

Levels of D-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice. Neurochem Int (2011) 0.93

Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Res (2009) 0.93

α7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia. Curr Pharm Des (2011) 0.93

Age-dependent responses of glial cells and leptomeninges during systemic inflammation. Neurobiol Dis (2008) 0.92

Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Eur J Pharmacol (2006) 0.92

Criterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophrenia. PLoS One (2011) 0.92

Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation. J Neuroimmunol (2005) 0.92

Prevalence of PTSD and depression among junior middle school students in a rural town far from the epicenter of the Wenchuan earthquake in China. PLoS One (2012) 0.91